Evidence map›Paper›PMID 36039644›Full record

ArticleImmunity, inflammation and disease2022

Impaired immunity and high attack rates caused by SARS-CoV-2 variants among vaccinated long-term care facility residents.

Dorothée Obach, Anna Solastie, Oona Liedes, Saimi Vara, Eva Krzyżewska-Dudek, Luise Brinkmann, Anu Haveri, Charlotte C Hammer, Timothée Dub, Seppo Meri and 3 more

Open access · goldAbstract read
In one paragraph

Article in Immunity, inflammation and disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 3 countries.

Dorothée ObachDepartment of Health Security, Infectious Disease Control and Vaccinations Unit, Finnish Institute for Health and Welfare, Helsinki, Finland.
Anna SolastieDepartment of Health Security, Expert Microbiology Unit, Finnish Institute for Health and Welfare, Helsinki, Finland.ORCID 0000-0002-3848-2768
Oona LiedesDepartment of Health Security, Expert Microbiology Unit, Finnish Institute for Health and Welfare, Helsinki, Finland.
Saimi VaraDepartment of Health Security, Expert Microbiology Unit, Finnish Institute for Health and Welfare, Helsinki, Finland.
Eva Krzyżewska-DudekDepartment of Bacteriology and Immunology, Translational Immunology Research Program, University of Helsinki, Finland.ORCID 0000-0002-5581-1690
Luise BrinkmannDepartment of Bacteriology and Immunology, Translational Immunology Research Program, University of Helsinki, Finland.
Anu HaveriDepartment of Health Security, Expert Microbiology Unit, Finnish Institute for Health and Welfare, Helsinki, Finland.ORCID 0000-0003-4620-7536
Charlotte C HammerDepartment of Health Security, Infectious Disease Control and Vaccinations Unit, Finnish Institute for Health and Welfare, Helsinki, Finland.
Timothée DubDepartment of Health Security, Infectious Disease Control and Vaccinations Unit, Finnish Institute for Health and Welfare, Helsinki, Finland.
Seppo MeriDepartment of Bacteriology and Immunology, Translational Immunology Research Program, University of Helsinki, Finland.ORCID 0000-0001-9142-501X
Tobias L FreitagDepartment of Bacteriology and Immunology, Translational Immunology Research Program, University of Helsinki, Finland.
Outi LyytikäinenDepartment of Health Security, Infectious Disease Control and Vaccinations Unit, Finnish Institute for Health and Welfare, Helsinki, Finland.
Merit MelinDepartment of Health Security, Expert Microbiology Unit, Finnish Institute for Health and Welfare, Helsinki, Finland.
Finnish Institute for Health and Welfare · FIUniversity of Helsinki · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionLong-term care facilities (LTCF) residents are at high risk for severe coronavirus disease 2019 (COVID-19), and therefore, COVID-19 vaccinations were prioritized for residents and personnel in Finland at the beginning of 2021.

methodsWe investigated COVID-19 outbreaks in two LTCFs, where residents were once or twice vaccinated. After the outbreaks we measured immunoglobulin G (IgG) antibodies to severe acute respiratory syndrome coronavirus 2 spike glycoprotein, neutralizing antibody (NAb) titers, and cell-mediated immunity markers from residents and healthcare workers (HCWs).

resultsIn LTFC-1, the outbreak was caused by an Alpha variant (B.1.1.7) and the attack rate (AR) among once vaccinated residents was 23%. In LTCF-2 the outbreak was caused by a Beta variant (B.1.351). Its AR was 47% although all residents had received their second dose 1 month before the outbreak. We observed that vaccination had induced lower IgG concentrations, NAb titers and cell-mediated immune responses in residents compared to HCWs. Only 1/8 residents had NAb to the Beta variant after two vaccine doses.

conclusionsThe vaccinated elderly remain susceptible to breakthrough infections caused by Alpha and Beta variants. The weaker vaccine response in the elderly needs to be addressed in vaccination protocols, while new variants capable of evading vaccine-induced immunity continue to emerge.

Indexed as

COVID-19SARS-CoV-2AgedHumansImmunoglobulin GIncidenceLong-Term CareSpike Glycoprotein, CoronavirusImmunoglobulin GSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2cell-mediated immunityCOVID-19elderlylong-term care facilityneutralizing antibodies

Identifiers

PMID36039644
PMCPMC9382858
OpenAlexW4292092778

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.